James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–858.
Ehteshami-Afshar S, FitzGerald J, Doyle-Waters M, Sadatsafavi M. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2016;20(1):11–23.
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. 2017 Report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582.
Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, Updated 2017. In: www ginasthma org. 2017.
Andersén H, Lampela P, Nevanlinna A, Säynäjäkangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J. 2013;7(4):342–6.
Nielsen M, Bårnes CB, Ulrik CS. Clinical characteristics of the asthma–COPD overlap syndrome–a systematic review. Int J Chron Obstruct Pulmon Dis. 2015;10:1443–54.
Boulet L-P, Hanania NA. The many faces of asthma-chronic obstructive pulmonary disease overlap. Curr Opin Pulm Med. 2019;25(1):1–10.
Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald J. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10(9):e0136065.
Wurst KE, Rheault TR, Edwards L, Tal-Singer R, Agusti A, Vestbo J. A comparison of COPD patients with and without ACOS in the ECLIPSE study. Eur Respir J. 2016;47(5):1559–62.
Walsh L, Wong C, S C, Guhan a, Pringle M, Tattersfield A: The prevalence of diagnosed asthma and COPD in a community population in Nottinghamshire Thorax 1996, 51:A26.
Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the US population. COPD. 2011;8(6):400–7.
De Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, Casali L, Ferrari M, Nicolini G, Panico MG. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985.
Miravitlles M, Soriano JB, Ancochea J, Munoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, García-Río F. Characterisation of the overlap COPD–asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053–60.
Menezes AMB, de Oca MM, Pérez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, Muiño A, Jardim JRB, Valdivia G, Tálamo C. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304.
Pleasants RA, Ohar JA, Croft JB, Liu Y, Kraft M, Mannino DM, Donohue JF, Herrick HL. Chronic obstructive pulmonary disease and asthma–patient characteristics and health impairment. COPD. 2014;11(3):256–66.
Lindström I, Luukkonen R, Vasankari T, Kanervisto M, Heliövaara M, Kainu A, Pallasaho P. Asthma, COPD and the risk of disability pension-11 year register-based follow-up study. Eur Respir J. 2015;46:PA356.
van Boven JF, Román-Rodríguez M, Palmer JF, Toledo-Pons N, Cosío BG, Soriano JB. Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life. Chest. 2016;149(4):1011–20.
Kumbhare S, Pleasants R, Ohar JA, Strange C. Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States. Ann Am Thorac Soc. 2016;13(6):803–10.
Ding B, DiBonaventura M, Karlsson N, Ling X: Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and wellness surveys. Int J Chron Obstruct Pulmon Dis 2016, 11:1139–1150.
Bonten TN, Kasteleyn MJ, de Mutsert R, Hiemstra PS, Rosendaal FR, Chavannes NH, Slats AM, Taube C. Defining asthma–COPD overlap syndrome: a population-based study. Eur Respir J. 2017;49(5):1602008.
Mannino DM, Gan WQ, Wurst K, Davis KJ. Asthma and chronic obstructive pulmonary disease overlap: the effect of definitions on measures of burden. Chronic Obstr Pulm Dis. 2017;4(2):87–96.
Kim J, Kim YS, Kim K, Oh Y-M, Yoo KH, Rhee CK, Lee JH. Socioeconomic impact of asthma, chronic obstructive pulmonary disease and asthma-COPD overlap syndrome. J Thorac Dis. 2017;9(6):1547.
Ferrante G, Baldissera S, Campostrini S. Epidemiology of chronic respiratory diseases and associated factors in the adult Italian population. Eur J Pub Health. 2017;27(6):1110–6.
Bui DS, Burgess JA, Lowe AJ, Perret JL, Lodge CJ, Bui M, Morrison S, Thompson BR, Thomas PS, Giles GG. Childhood lung function predicts adult chronic obstructive pulmonary disease and asthma–chronic obstructive pulmonary disease overlap syndrome. Am J Respir Crit Care Med. 2017;196(1):39–46.
Baarnes CB, Andersen ZJ, Tjønneland A, Ulrik CS. Incidence and long-term outcome of severe asthma–COPD overlap compared to asthma and COPD alone: a 35-year prospective study of 57,053 middle-aged adults. Int J Chron Obstruct Pulmon Dis. 2017;12:571–9.
Kendzerska T, Sadatsafavi M, Aaron SD, To TM, Lougheed MD, FitzGerald JM, Gershon AS, Network CRR. Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: a population study of prevalence, incidence and mortality. PLoS One. 2017;12(3):e0173830.
Senthilselvan A, Beach J. Characteristics of asthma and COPD overlap syndrome (ACOS) in the Canadian population. J Asthma. 2018:1–9.
Henriksen AH, Langhammer A, Steinshamn S, Mai X-M, Brumpton BM. The prevalence and symptom profile of asthma–COPD overlap: the HUNT study. COPD. 2018;15(1):27–35.
Ekerljung L, Mincheva R, Hagstad S, Bjerg A, Telg G, Stratelis G, Lötvall J. Prevalence, clinical characteristics and morbidity of the asthma-COPD overlap in a general population sample. J Asthma. 2018;55(5):461–9.
Mindus S, Malinovschi A, Ekerljung L, Forsberg B, Gíslason T, Jõgi R, Franklin KA, Holm M, Johannessen A, Middelveld R. Asthma and COPD overlap (ACO) is related to a high burden of sleep disturbance and respiratory symptoms: results from the RHINE and Swedish GA2LEN surveys. PLoS One. 2018;13(4):e0195055.
Morgan BW, Grigsby MR, Siddharthan T, Chowdhury M, Rubinstein A, Gutierrez L, Irazola V, Miranda JJ, Bernabe-Ortiz A, Alam D. Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low-and middle-income countries. J Allergy Clin Immunol. 2019;143(4):1598–606.
Mendy A, Forno E, Niyonsenga T, Carnahan R, Gasana J. Prevalence and features of asthma-COPD overlap in the United States 2007–2012. Clin Respir J. 2018;12(8):2369–77.
Kumbhare S, Strange C. Mortality in asthma-chronic obstructive pulmonary disease overlap in the United States. South Med J. 2018;111(5):293–8.
Koleade A, Farrell J, Mugford G, Gao Z. Prevalence and risk factors of ACO (asthma-COPD overlap) in aboriginal people. J Environ Public Health. 2018;2018:4657420.
Guerriero M, Caminati M, Viegi G, Senna G, Pomari C. Prevalence and features of asthma–chronic obstructive pulmonary disease overlap in northern Italy general population. J Asthma. 2019;56(1):27–33.
Kang H-R, Hong S-H, Ha S-Y, Kim T-B, Lee E-K. Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea. Respir Res. 2019;20(1):80.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147–53.
Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994:1088–101.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Shantakumar S, Pwu R-F, D’Silva L, Wurst K, Kuo Y-W, Yang Y-Y, Juan Y-C, Chan KA. Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study. BMC Pulm Med. 2018;18(1):16.
Sevimli N, Yapar D, Türktaş H. The prevalence of asthma-COPD overlap (ACO) among patients with asthma. Turk Thorac J. 2019;20(2):97–102.
Kiljander T, Helin T, Venho K, Jaakkola A, Lehtimäki L. Prevalence of asthma–COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional study. NPJ Prim Care Respir Med. 2015;25:15047.
Tommola M, Ilmarinen P, Tuomisto LE, Lehtimäki L, Haanpää J, Niemelä O, Kankaanranta H. Differences between asthma–COPD overlap syndrome and adult-onset asthma. Eur Respir J. 2017;49(5):1602383.
Harada T, Yamasaki A, Fukushima T, Hashimoto K, Takata M, Kodani M, Okazaki R, Takeda K, Watanabe M, Kurai J. Causes of death in patients with asthma and asthma–chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2015;10:595–602.
Watanabe M, Noma H, Kurai J, Sano H, Ueda Y, Mikami M, Yamamoto H, Tokuyasu H, Kato K, Konishi T. Differences in the effects of asian dust on pulmonary function between adult patients with asthma and those with asthma–chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:183–90.
Varmaghani M, Dehghani M, Heidari E, Sharifi F, Moghaddam SS, Farzadfar F. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47–57.
Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, Aichour AN, Aichour I, Aichour MTE, Alam K. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5(9):691–706.